United States Ophthalmic Atlases
Market Scope’s United States ophthalmic atlases identify treatment opportunity at the metro level for the top 85 metros—identifying high-opportunity and diseased populations, procedure volumes, premium penetration rates, surgeon counts, surgical locations, and much more. Companies often use this data throughout the development and commercialization processes to identify ideal clinical trial locations, develop launch strategies, define sales territories, allocate resources, and optimize sales and marketing initiatives.
Provided by metro
- Identification of high-opportunity population
- Procedure volumes by type
- Surgeon profiles by volume category
- ASC profiles: Counts and average procedure volumes
- Demographic profiles: Population by age group, median age, household income, and diseased population
- Much more varying by atlas subspecialty
Use cases
- Development of product launch strategies
- Sales territory analysis
- Clinical trial site selection
- Allocation of resources
- Identifying metro-level market share
- Comparing market potential between metros
Methodology
Market Scope uses the proprietary MedOp Index™ Analysis to examine market potential and provides a benchmark against other metros. Each clinical area atlas considers multiple factors to identify opportunity. For example, the cataract MedOp Index™ considers the concentration of active, affluent seniors; the number of high-volume cataract surgeons; and ASC counts and volumes, while the retina MedOp Index™ considers annual IVT injections and vitrectomies per provider; the geographic concentration of diabetics; the total population with retinal diseases; and high-volume retinal care providers.
Available Atlases
Learn More
Contact us using the button below to request more information on atlas coverage, view a demo, or schedule a time to discuss this live with our team.
Join Market Scope Today
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.